Study of GS-0151 in Participants With Rheumatoid Arthritis

NCT06902519 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: GS-0151
DRUG: Placebo

Sponsor

Gilead Sciences